Q-omics provides the consensus-scored HNRNPA1P27 profile across patient tissues and cancer cell-line models. HNRNPA1P27 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, HNRNPA1P27 is differentially expressed in 12, with the highest sampling consensus in THCA. Additionally, HNRNPA1P27 RNA expression shows 14,362 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRP, THCA, and THYM as cancer lineages where HNRNPA1P27 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for HNRNPA1P27 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes HNRNPA1P27 survival associations across molecular data types. HNRNPA1P27 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible HNRNPA1P27 RNA expression–survival associations across cancer types. High HNRNPA1P27 expression shows unfavorable associations in KIRP, KIRC, STAD and KICH, but favorable associations in COAD and BLCA. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify KIRP as the clearest survival context for HNRNPA1P27 RNA expression.
This table summarizes HNRNPA1P27 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for HNRNPA1P27. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. HNRNPA1P27 shows higher tumor expression in THCA, KIRC, COAD, LUAD, LIHC and BRCA. The THCA box plot shows higher HNRNPA1P27 RNA expression in tumor versus normal tissue (log2 FC = +2.675, t-test p < 0.001).
This table shows molecular features associated with HNRNPA1P27 in patient tissues and cancer cell lines. In patient samples, HNRNPA1P27 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
